Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents with Narcolepsy

Study Title
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Teva Identifier
C10953/1100 | 2012-005510-20
ClinicalTrials.gov Identifier
NCT01624480
Study Status
Completed
Trial Condition(s)
Narcolepsy
Interventions
Drug: Armodafinil

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
6 Years to 17 Years
Trial Duration
07/01/2012 - 12/01/2015
Phase
Phase 1

Study Type

Interventional